PL2623495T3 - Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę - Google Patents

Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę

Info

Publication number
PL2623495T3
PL2623495T3 PL13153470T PL13153470T PL2623495T3 PL 2623495 T3 PL2623495 T3 PL 2623495T3 PL 13153470 T PL13153470 T PL 13153470T PL 13153470 T PL13153470 T PL 13153470T PL 2623495 T3 PL2623495 T3 PL 2623495T3
Authority
PL
Poland
Prior art keywords
positively charged
skin penetration
penetration rate
charged water
soluble prodrugs
Prior art date
Application number
PL13153470T
Other languages
English (en)
Inventor
Chongxi Yu
Lina Xu
Original Assignee
Techfields Biochem Co Ltd
Chongxi Yu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techfields Biochem Co Ltd, Chongxi Yu filed Critical Techfields Biochem Co Ltd
Publication of PL2623495T3 publication Critical patent/PL2623495T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/30Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL13153470T 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę PL2623495T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13153470.3A EP2623495B1 (en) 2006-09-03 2006-09-03 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
PCT/IB2006/053090 WO2008029199A1 (en) 2006-09-03 2006-09-03 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
EP06795893.4A EP2084132B1 (en) 2006-09-03 2006-09-03 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate

Publications (1)

Publication Number Publication Date
PL2623495T3 true PL2623495T3 (pl) 2019-11-29

Family

ID=39156867

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13153470T PL2623495T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów n-aryloantranilowych o bardzo dużej szybkości przenikania przez skórę
PL06795893T PL2084132T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL06795893T PL2084132T3 (pl) 2006-09-03 2006-09-03 Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry

Country Status (6)

Country Link
EP (2) EP2623495B1 (pl)
CN (1) CN101506168B (pl)
ES (2) ES2735287T3 (pl)
HK (1) HK1137426A1 (pl)
PL (2) PL2623495T3 (pl)
WO (1) WO2008029199A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
EP2084124B9 (en) 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
CN101541743A (zh) 2006-11-08 2009-09-23 于崇曦 多肽及相关化合物的透皮给药系统
EP2656879B1 (en) 2006-12-10 2017-06-28 Chongxi Yu Transdermal delivery systems of beta-lactam antibiotics
PL2125697T3 (pl) 2007-01-15 2017-01-31 Yu Dodatnio naładowane, rozpuszczalne w wodzie proleki retinoidów i związków podobnych do retinoidów o bardzo wysokich współczynnikach przenikania przez skórę
JP5389668B2 (ja) 2007-01-31 2014-01-15 チョンシー ユー 皮膚浸透率の非常に高い1H−イミダゾ[4,5−c]キノリン−4−アミン及び関連化合物の正に荷電した水溶性プロドラッグ
KR20190091378A (ko) * 2007-06-04 2019-08-05 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도
WO2009037705A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
EP2203411B1 (en) 2007-09-20 2016-01-06 Ramot at Tel-Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
KR20210123406A (ko) 2008-12-04 2021-10-13 충시 위 고투과력을 가진 조성물 및 이의 적용
PL2427475T3 (pl) 2009-05-08 2021-07-19 Techfields Biochem Co., Ltd. Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
US20120022116A1 (en) * 2010-07-20 2012-01-26 Huayun Deng Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
KR102443057B1 (ko) * 2012-01-18 2022-09-14 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
WO2014139161A1 (en) 2013-03-15 2014-09-18 Techfields Pharma Co., Ltd. Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
US20160168108A1 (en) 2014-12-16 2016-06-16 Adt Pharmaceuticals, Inc. Method of treating or preventing ras-mediated diseases
US9862698B2 (en) 2014-12-16 2018-01-09 Adt Pharmaceuticals, Inc. Indenyl compounds, pharmaceutical compositions, and medical uses thereof
US11186596B2 (en) 2018-04-26 2021-11-30 Adt Pharmaceuticals, Llc Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses
WO2020070557A1 (en) * 2018-10-02 2020-04-09 Q Biomed Inc. Modified therapeutic agent analogs of mefenamic acid
US20220267270A1 (en) * 2019-08-30 2022-08-25 University Of South Florida Sting modulators, compositions, and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB100208A (en) * 1915-03-24 1917-03-01 Isidore Swientoslawsk Morrison Improvements in Watch Movements.
US2671805A (en) * 1952-07-02 1954-03-09 Searle & Co Basically substituted o-arylamino-benzamides
GB984471A (en) * 1961-01-12 1965-02-24 Parke Davis & Co Anthranilic acid esters and methods for producing the same
BE630053A (pl) * 1962-03-27
US3420871A (en) * 1964-09-01 1969-01-07 Parke Davis & Co Anthranilic acid esters
DK121236B (da) * 1967-07-03 1971-09-27 Gea As Analogifremgangsmåde til fremstilling af terapeutisk aktive, basisk substituerede amider af N-substituerede antranilsyrer, eller syreadditionssalte deraf.
GB1187259A (en) * 1967-10-23 1970-04-08 Hexachimie New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
US3814811A (en) * 1972-06-07 1974-06-04 Andreu Sa Dr Method of eliminating or alleviating local pain with diethylaminoethyl flufenamate
JPS57183738A (en) * 1981-05-06 1982-11-12 Yamanouchi Pharmaceut Co Ltd Aromatic carboxylic acid derivative
JPS6452742A (en) * 1987-04-27 1989-02-28 Syntex Pharma Int Omega-quaternary ammonium alkyl ester and thioester of acidic non-steroidal antiinflammatory
US5654337A (en) 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
AUPN531195A0 (en) 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
KR100213465B1 (ko) 1996-11-01 1999-08-02 최좌진 케토프로펜 패취 조성물
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
DE69939019D1 (de) 1998-07-07 2008-08-14 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht-irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
US6416772B1 (en) 2001-01-12 2002-07-09 H. Wayne Van Engelen Topical dermal anaesthetic
US6528040B1 (en) 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
US7052715B2 (en) 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof

Also Published As

Publication number Publication date
CN101506168A (zh) 2009-08-12
PL2084132T3 (pl) 2019-03-29
ES2735287T3 (es) 2019-12-17
WO2008029199A1 (en) 2008-03-13
EP2084132B1 (en) 2018-08-08
EP2623495B1 (en) 2019-05-01
EP2084132A1 (en) 2009-08-05
ES2694685T3 (es) 2018-12-26
HK1137426A1 (en) 2010-07-30
EP2623495A1 (en) 2013-08-07
EP2084132A4 (en) 2010-05-26
CN101506168B (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
HK1137426A1 (en) Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
HK1137425A1 (en) Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
HK1215805A1 (zh) 具有快速皮膚穿透速度的帶正電荷的水溶性雙氯芬酸前藥
PT2049482E (pt) Profármacos solúveis em água carregados positivamente de ácidos aril- e heteroarilacéticos com velocidade de penetração na pele muito rápida
HK1135958A1 (en) Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
HK1202524A1 (en) Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
PL2061749T3 (pl) Dodatnio naładowane, rozpuszczalne w wodzie proleki acetaminofenu i związków pokrewnych o bardzo dużej szybkości przenikania przez skórę
HK1136814A1 (en) Positively charged water-soluble prodrugs of diflunisal and related compounds with very fast skin penetration rate
EP2084165A4 (en) PRO-DRUGS OF WATER-SOLUBLE OXICAMS POSITIVE AND RELATED COMPOUNDS WITH VERY HIGH SKIN PENETRATION SPEED
IL217370A (en) New nucleic acid matrices and methods for using them
EP2647644A4 (en) RNA MODIFIED BY 2'-O
PT2391620E (pt) Dicianopiridinas substituídas por alquilamina e seus profármacos de ésteres de aminoácidos
GB2452358B (en) Preparation of bile acids
EP2453856A4 (en) METHOD FOR THE ADMINISTRATION OF APPROPRIATIONS IN THE HEADLINK
HK1216096A1 (zh) 具有快速皮膚穿透速度的帶正電荷的水溶性的芥子類化合物及其相關化合物的前藥
SI2189442T1 (sl) Postopek in intermediati za pripravo aliskirena
EP2032526A4 (en) UNSATURATED ALKYL ESTERS FROM 5-AMINOLEVULINIC ACID AND THEIR PREPARATION AND USE
HK1208184A1 (en) Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
ZA200908631B (en) N-Oxides of venlafaxine and O-Desmethylvenlafaxine as prodrugs
HK1208214A1 (en) Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
EP2373306A4 (en) ALISKIRENE WITH TRANSVERSE ADMINISTRATION
IL202464A0 (en) N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
HK1202115A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
HK1200031A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
GB0912493D0 (en) Preparation of bile acids and intermediates thereof